European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Glaxo Group Ltd., Stevenage

Watch
Glaxo Group Ltd.

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Glaxo Group Ltd.

Identification

Chp
Companies House 00305979
Lei
5493006TSD23CIX01B10

Address

Gunnels Wood Road, Gsk Medicines Research Centre, Stevenage SG1 2NY, United Kingdom
980 Great West Road Brentford Middlesex, United Kingdom
Gsk Medicines Research Centre Gunnels Wood Road Stevenage, United Kingdom

Corporate purpose

70.10
Activities of head offices

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
1Director
1Secretary
2Director
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
CSV export

Investigative Journalism

Uncover International Corporate Connections
with our Free Investigative-Account

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Portfolio and Investments
19 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Taxes
Cash on hand
Liabilities
Trademarks
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

Year 2026 in Euipotm
93 trademark filings (89 wordmarks, 2 word figurative marks, 2 other marks): ADVOQAY, ALENYS, AMZATBI, ANFIBRIQ, BAYFORLA, BELHIRVI, BEYDUVI, BEYORLI, BEYREZFOR, BEYVIKLI, BFORSEV, BMOPHORE, BREMORVU …
10 Aug 2026 also 10/10/2016, 04/10/2015, 03/10/2014, 07/08/2013, 28/09/2012, 28/09/2011, 18/08/2010, 04/06/2009, 30/10/2008, 31/10/2007, 21/09/2006, 07/04/2005
Full accounts made up to 2025-12-31
Year 2026 in Dpmam
1 word figurative mark: BECOTIDE, DERMOFORTE, PD3D, ROTAHALER, Sanasthmyl, Wenti …
31 Mar 2026 also 30/07/2025, 15/08/2024, 15/08/2023, 18/08/2022, 10/08/2021, 25/08/2020, 29/08/2019, 28/08/2018, 15/08/2017
Confirmation statement made with no updates
Year 2025 in Euipotm
39 trademark filings (34 wordmarks, 3 figurative marks, 2 word figurative marks): ADVOQAY, BAYFORLA, BEYOND THE NOSE, BEYORLI, BOWDERZIN, BREKVUE, CIMTOPIA, DACFORLY, DIVANAGE, ELMENDOS, ENTRAREG …
Year 2025 in Dpmam
1 word figurative mark: ERADIPAK, EURAMIG, INTEGRA, MALANIL, MALVONE, NARADOL, NARAGRAN, NARDOL, PD3D, TINEAFAX …
1 Aug 2025
Annual report for the year ending 31/12/2024
28 Jul 2025
No longer Director: Julie Belita Brown
Year 2024 in Euipotm
31 trademark filings (28 wordmarks, 1 figurative mark, 2 word figurative marks): BOSATRIA, CELAMIR, CERT, CIMTOPA, CIMTOPEX, COBOSEC, COBOSEQ, CORSERVE, CUBRAXIS, DEZATE, ELICODIL, FRESPIRIS …
23 Sept 2024
Director's details changed for Mrs Julie Belita Brown · Secretary's details changed for Mrs Victoria Anne Whyte
17 Sept 2024
Director's details changed for Mr Adam Walker
11 Sept 2024
Director's details changed for The Wellcome Foundation Limited · Change of details for Glaxosmithkline Finance Plc as a …
9 Aug 2024
Annual report for the year ending 31/12/2023
18 Jul 2024
Address
Year 2024 in Epobase
4 European patent filings: Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)OXY]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol …
2 Feb 2024 via Cellzome GmbH
Shareholding: Cellzome GmbH
Year 2024 in Dpmam
5 trademark filings: EURAMIG, NARADOL, NARAGRAN, NARDOL, PHARMASSIST
6 Dec 2023 via Glaxosmithkline IHC Ltd.
No longer Director: Glaxosmithkline IHC Ltd
Year 2023 in Euipotm
4 trademark filings (2 wordmarks, 1 figurative mark, 1 word figurative mark): UNIVERSAL DISCOUNT, UNIVERSAL EXTRA …
Year 2023 in Dpmam
76 trademark filings: ATMADISC, BACTROBAN, BETNOVATE, DERMOVATE, EUMOVATE, EVOHALER, FLIXONASE, GLAXO WELLCOME, PD3D, ROTACAPS, ROTAHALER, SEROXAT, Wenti, ZOVIRAX, ZoVirax …
6 Sept 2023
Patent: Bcma (CD269/Tnfrsf17) - Binding Proteins
16 Aug 2023
Annual report for the year ending 31/12/2022
9 Jun 2023
Address
6 Jun 2023
Address
11 May 2023
Director: Julie Belita Brown
29 Nov 2022
Annual report for the year ending 31/12/2021
Year 2022 in Euipotm
16 trademark filings (15 wordmarks, 1 word figurative mark): BELATIV, BLUVEAU, ENCOURCYA, ENCOURZIA, ENTEREG, FEMASUR, JERSALM, LUTAVA, LUTAVI, PLISTREL, POSIVENT, STRIMVELIS, TRELAVUS, VARONEVE …
9 Nov 2022
Patent: An output device
2022 in Chfd
No longer Director (17 companies)
Year 2022 in Euipods
31 registered designs
Year 2022 in Dpmam
1 other mark: ATMADISC, BECOTIDE, BETABACTYL, BETNOVATE, DERMOFORTE, DERMOVATE, ERADIPAK, GLAXO WELLCOME, INTEGRA, MALANIL, MALVONE, PD3D, ROTACAPS, ROTAHALER, SEROXAT …
6 Jun 2022
Memorandum and Articles of Association · 47(3)(B) to the companies act 2006, the directors are hereby given authority …
18 May 2022
Patent: Counter for use in a medication delivery device
2021 in Chfd
Director: GSK Capital B.V., Glaxosmithkline Export Ltd. · No longer Director (5 companies)
20 Dec 2021 via Cellzome GmbH
Shareholder: Cellzome GmbH
Year 2021 in Euipotm
14 trademark filings (11 wordmarks, 3 word figurative marks): BEACON COMMUNITY, BELAMAF, ECLIPSE, EUMOWASH, LUMIA, MAGERION, PRD, PRIMISA, PRO ACTIVE REGULAR DOSING, RELVARE, SYLVAIR …
Year 2021 in Dpmam
5 other marks: ELOBACT, Elobact, FORTAM, FORTUM, PD3D, ZINACEF, ZINNAT …
Year 2021 in Euipods
26 registered designs
30 Sept 2021
Annual report for the year ending 31/12/2020
Year 2021 in Epobase
6 European patent filings: Medicament Dispenser …
18 Aug 2021 via GSK PSC Poland sp. z o.o.
Shareholding: GSK PSC Poland sp. z o.o
2020 in Chfd
Director: GSK Consumer Healthcare Holdings NO. 2 LLC, Tesaro UK Ltd. · No longer Director (7 companies)
Year 2020 in Dpmam
43 trademark filings (1 wordmark, 5 figurative marks, 12 other marks): ATMADISC, BACTROBAN, BECOTIDE, BETABACTYL, BETNOVATE, CAZOR, CLAVULOX, CLAVUMOX, DERMOVATE, DISKHALER, ERADIPAK, EVOHALER …
Year 2020 in Euipotm
6 trademark filings (4 wordmarks, 1 word figurative mark, 1 other mark): EPINOVA DPU, FLONASE, OXISTAT, ZALNUCA …
Year 2020 in Epobase
10 European patent filings: USE of LP-PLA2 Inhibitors in the Treatment and Prevention of EYE Diseases …
Year 2020 in Euipods
5 registered designs
26 Aug 2020
Annual report for the year ending 31/12/2019
Year 2019 in Euipods
53 registered designs
2019 in Chfd
No longer Director: Mixis Genetics Ltd., Stiefel Laboratories (Maidenhead) Ltd. · Director (6 companies)
Year 2019 in Epobase
11 European patent filings: Improved Anti-Serum Albumin Binding Variants …
Year 2019 in Euipotm
21 trademark filings (15 wordmarks, 6 word figurative marks): ALABRE, AVASPIR, BRIALEV, FLONASE, MORE, NILZOVI, OXATEVE, QUOMEM, REVTRAN, SELF-CARE TRANSFORMERS, SERIPIDIL, TRIAIR, VARONEVE, XBALCI …
Year 2019 in Dpmam
1 other mark: AMMIDENT, AMPICLOX, ANAVUE, CYTORULAN, FLIXOVENT, FLUTIVATE, FORTIVA, LACIPIL, MIVACRON, MIVATRAN, NIMBEX, NIMBIUM, NURAMEX, NUROMAX, NUROMEX …
25 Sept 2019
Annual report for the year ending 31/12/2018
15 May 2019
Appointment of Mr Iain James Mackay as a director
7 May 2019
No longer Director: Simon Paul Dingemans
Year 2018 in Dpmam
33 trademark filings: AERUGIPEN, ALENIZ, ASTHMOGIT, Athemur, BECODISK, CEPOREXIN, CORTISPORIN, CYTEFURAN, CardioCast, Elibact, EuMeCast, FLIXOVATE, Flubil, GIRAHALER, GLAXO …
Year 2018 in Euipods
126 registered designs
Year 2018 in Epobase
16 European patent filings: A Dispensing Device …
28 Sept 2018
Annual report for the year ending 31/12/2017
Year 2018 in Euipotm
33 trademark filings (32 wordmarks, 1 word figurative mark): ALISADE, BECOTIDE, CORFLUENT, CPEZAQ, EJEMGA, FYPAVI, FYPEVU, HULTEBA, ICREBDA, LADRUPI, LISLEKRA, LITIMIC, MAGISTO, MEMRIC, MODLEVY …
22 Aug 2018 via NTG Nordic Transport Group A/S
Shareholding, No longer Voting rights: Neurosearch A/S
22 Jun 2018 via Corporate Health and Performance
Director: Corporate Health and Performance
Year 2017 in Epobase
24 European patent filings: Capsule for a Powder Medicament …
Year 2017 in Dpmam
30 trademark filings: ANDREWS, AQUAFRESH PROTECT, ATLAZIR, Andrews Liver Salt, BECLOFORTE, BECOTIDE, BENEFACT, EUMOVATE, GLUCOWELL, IMMIGRAN, LAMICTINE, NARAGRAN, NARATREX, NASULE, Pulmochron …
14 Dec 2017 via Glaxosmithkline Consumer Healthcare (UK) (NO.1) Ltd.
Director: Novartis Consumer Health UK Ltd
Year 2017 in Euipotm
25 trademark filings (23 wordmarks, 1 word figurative mark, 1 other mark): ALIUXTA, ARLEAVIB, BENEFACT, BIZURBA, BRAVOZAN, CYSIMRA, GENELABS, LOGIC, MAGERION, MAGEXTEN, MICROAIR, MODARRO, PNEUMORADAR …
7 Oct 2017
Annual report for the year ending 31/12/2016
Year 2017 in Euipods
34 registered designs
Year 2016 in Dpmam
61 trademark filings: AQUAFRESH, AQUAFRESH FLEX, AQUAFRESH FLEX 'N' DIRECT, AQUAFRESH WHITENING, Aquafresh, Beecham Resolve, CEPORIN, ENO, FIXFRISCH, FLEXAROO, FLEXI-AMP, FLEXOCAT, FLEXOSAURUS …
Year 2016 in Euipotm
17 trademark filings (14 wordmarks, 2 figurative marks, 1 word figurative mark): ALACYS, ATLETIS, BABYHALER, CYMCIR, FLUTIDE, GQ, INNERGY, LAMICTAL, LIVE EVERY BREATH, MINAXAR, NEUTONE, REGARIA …
6 Dec 2016 via Galvani Bioelectronics Ltd.
No longer Director: Galvani Bioelectronics Ltd
Year 2016 in Epobase
18 European patent filings: Antigen-Binding Constructs …
22 Aug 2016
Confirmation statement made with updates
4 Aug 2016 via Haleon UK Finance (USD) Ltd.
Director: Haleon UK Finance (USD) Ltd
Year 2016 in Euipods
4 registered designs
1 Mar 2016
No longer Director (1)
3 Feb 2016 via Galvani Bioelectronics Ltd.
Director: GSK Bioelectronics (NO.1) Ltd
2015 in Chfd
Director: Stiefel Consumer Healthcare (UK) Ltd., Glaxosmithkline Consumer Healthcare SRI Lanka Holdings Ltd. · Limited Partner: Translational Research Funding LLP · No longer Director: LEO Osprey Ltd.
Year 2015 in Epobase
21 European patent filings: Denture Adhesive …
24 Nov 2015
Director: Adam Walker
Year 2015 in Euipotm
40 trademark filings (33 wordmarks, 3 figurative marks, 2 word figurative marks, 2 other marks): ACTIFOAM, ACTIMOUSSE, ACTION 12H, ALLEAU, ATARGO, BETNOVATE, BRAVINU, ELEGAIN, ENTEREGA, FABIOR …
Year 2015 in Dpmam
277 trademark filings (1 wordmark, 1 other mark): ACCUHALER, AERUGIPEN, ALENIZ, AMM-I-DENT, ANAVUE, AQUAFRESH, AQUAFRESH FLEX, AQUAFRESH PROTECT, AQUAFRESH WHITENING, ASTHMOGIT, ATLAZIR, ATMADISC …
26 Aug 2015
Capital: £809M
Year 2015 in Euipods
6 registered designs
Year 2014 in Euipods
21 registered designs
Year 2014 in Euipotm
38 trademark filings (29 wordmarks, 9 other marks): AUGMENTIN, BREO ELLIPTA, CYTEFURAN, DOLSINAL, EAT, SPEAK AND SMILE WITH CONFIDENCE, ESSENCE STIMULATE YOUR SENSES, EUPECLANIC, IMIGRAN INSTREAM …
Year 2014 in Epobase
21 European patent filings: 3-Amino-Pyrazole Derivatives Useful Against Tuberculosis …
Year 2014 in Dpmam
1 wordmark: ACTIPARINE, AMIPARINE, AMM-I-DENT, AMMIDENT, AMOXYFLOX, AMPICLOX, ANAFLON, BAPARINE, BEECHAM, BETNESALIC-N, CEPOVENIN, CLAMOFLOX, CLAVUCID, CardioCast, EUMOVATE …
2014 in Chfd also 27/11/2009
Director (6 companies)
18 Aug 2014
Capital: £809M
Year 2013 in Epobase
54 European patent filings: Guide Device for a Liquid Dispenser …
Year 2013 in Dpmam
343 trademark filings: ACCUHALER, ACTIPARINE, ALENIZ, AMIPARINE, ANAVUE, ANDREWS, ASTHMOGIT, ATEMUR, ATLAZIR, ATMADISC, AUGMENTAN, AUGMENTAN SR, AUGMENTIN, Aeromax, Andrews Liver Salt …
Year 2013 in Euipotm
19 trademark filings (16 wordmarks, 1 figurative mark, 2 word figurative marks): AIRTIME, ALLEN & HANBURYS, AMTARQ, ANASTAR, ANORO, AZINTREL, DISKUS, EMO, EMTARQ, IMIGRAN SPRINTSOLVE, IMIGRAN TOPTAB …
Year 2013 in Euipods
40 registered designs
16 Aug 2013
Capital: £809M
10 Jul 2013 via GSK Equity Investments NO2 Ltd.
Director: GSK Equity Investments NO2 Ltd
8 Mar 2013
Address
18 Feb 2013 via Cellzome Ltd.
Director: Cellzome Ltd
Year 2012 in Euipotm
21 trademark filings (17 wordmarks, 3 figurative marks, 1 word figurative mark): 3FACH-PROPHYLAXE, AJUCOVE, AUGMENTINE DUO, ELEBRATO, GROW UP ONE DAY, JOVOYCE, MAXCARB, Maxiraw, PENTATHLON, PENTHIFRA …
Year 2012 in Epobase
69 European patent filings: Oral Care Composition Comprising Particulate Zinc Oxide …
Year 2012 in Dpmam
80 trademark filings: ACCUHALER, ACTIVIR, AMM-I-DENT, AMMIDENT, AMOXIL, AMPICLOX, ANAFLON, AZINTREL, BACTROBAN, BASIPARIN, BRETHYLAT, CICATREX, CLAVIR, COLVIR, CardioCast …
2012 in Chfd
Director (5 companies)
14 Sept 2012 also 16/09/2010
Annual return made up to 2012-08-15 with full list of shareholders
Year 2011 in Epobase
78 European patent filings: Azabicyclo [3. 1. 0]Hexyl Derivatives AS Modulators of Dopamine D3 Receptors …
Year 2011 in Euipotm
28 trademark filings (24 wordmarks, 3 word figurative marks, 1 other mark): AIRRIVE, ASLERA, ASSENTI, BALESTRA, ELLIPTA, EXTREME CLEAN, FLIXOTIDE, FREESPIRE, GALAXYDR, GLYSTAR, JYRAZ, MICROCLEAN …
Year 2011 in Dpmam
56 trademark filings: AMM-I-DENT, AMMIDENT, AMPICLOX, ANAFLON, Angitropin, Ansin, BASISCREAM, BETNESALIC, BETNESOL, CEPORIN, CardioCast, EUMOVATE, EURAMIG, EuMeCast, FLIXOVENT …
5 Oct 2011
Director's details changed for The Wellcome Foundation Limited · Director's details changed for Edinburgh …
26 Sept 2011
Annual return made up to 2011-08-15 with full list of shareholders · Director's details changed for The Wellcome …
23 Sept 2011
Address
2011 in Chfd
No longer Director: Tres Cantos Open LAB Foundation · Director (6 companies)
8 Apr 2011
Director: Simon Paul Dingemans
6 Apr 2011
No longer Director (1)
3 Mar 2011
No longer Secretary (1)
Year 2010 in Epobase
135 European patent filings: Azabicyclo (3.1.0) Hexane Derivatives Useful AS Modulators of Dopamine D3 Receptors …
Year 2010 in Dpmam
91 trademark filings: 3TC, AGENERASE, ALKERAN, AQUAFRESH PROTECT, AXOBAN, AXOTIDE, AZT, Almet, Almetol, BETNESALIC, BRISOFORTE, BRISONASE, BRISOVENT, CALPOL, CASOR …
Year 2010 in Euipotm
13 wordmarks: AUGMENTIN DUO, AUGMENTIN XL, BREO, ELLIPTUS, GEMDISK, GEMISYS, RELVAR, ROTACAPS, SANTRON, ZENTEL, ZOVIPATCH, ZYLORIC, ZYSTAR
16 Nov 2010
Registered Design: Cardboard boxes [packaging]
1 Jul 2010 via Tres Cantos Open LAB Foundation
Director: Tres Cantos Open LAB Foundation
18 May 2010 via Glaxosmithkline IHC Ltd.
Director: Glaxosmithkline IHC Ltd
4 Apr 2010
Patent: Verfahren zur Herstellung eines 1-(Alkylamino)-2-nitroethenthiol-kaliumsalzes, Verfahren zur Herstellung eines N-substituierten 1-Alkylthio-2-nitroethenamins, Verfahren zur Herstellung von N …
3 Mar 2010
Deed of assignment with smithkline corporation 23/10/2009
Year 2009 in Epobase
123 European patent filings: A Fluid Dispensing Device …
Year 2009 in Dpmam
3 wordmarks: 3TC, ACCUHALER, ADJUQUA, AMPICLOX, ANAFLON, ANAVUE, ASTHMOGIT, ATEMUR, ATMADISC, AXOBAN, AXOTIDE, AZINTREL, Aeromax, Aurantex, BABYHALER …
Year 2009 in Euipotm
16 trademark filings (14 wordmarks, 2 word figurative marks): ACTI-FLUOR, ALLEN & HANBURYS, ALTISPIR, BEECHAM, CYTORULAN, DETOVIX, DUALAIR, EXTREME CLEAN, MIRAVAIR, NUVAIRE, THE SCIENCE OF TRIPLE …
11 Dec 2009
Purchase agreement 04/12/2009
12 Nov 2009
Memorandum and Articles of Association · Resolution of Memorandum and/or Articles of Association · Dividend 29/10/2009
14 Oct 2009
Address
1 Oct 2009 in Ukri
UK funding (£14,962.00): Realising the potential of next generation printed phatmaceuticals
19 Aug 2009 also 04/09/2008, 20/09/2007, 19/09/2005
Return made up to 15/08/09; full list of members
17 Aug 2009 via NTG Nordic Transport Group A/S
Shareholding, Voting rights: Neurosearch A/S
18 Feb 2009
Registered Design: A cover, in particular for a microfluidic chip
18 Feb 2009
Registered Design: A cover, in particular for a microfluidic chip
17 Feb 2009
Registered Design: Holders for microfluidic chip structures
Year 2008 in Epobase
207 European patent filings: Method for Making a Blister Package …
Year 2008 in Euipotm
79 trademark filings (57 wordmarks, 4 figurative marks, 14 word figurative marks, 4 other marks): + PLUS DEVICE, ACYRAX, ALTARGO, AMPICLOX, AVAMYS, CLAVULIN, COBOSEC, COBOSEQ, DIVANAGE, DON'T FORGET …
Year 2008 in Dpmam
4 word figurative marks: ACTIPARINE, ACTIVIR, ADJULAT, AERUGIPEN, AIROTAB, ALKERAN, AMIPARINE, AMM-I-DENT, AMMIDENT, AMOXIL, AMOXYFLOX, AMPICLOX, ANAFLON, ANDREWS, AQUAFRESH …
Year 2007 in Epobase
164 European patent filings: Substituted Isoquinolines Useful in the Treatment of Diseases Such AS Cancer and Atherosclerosis …
Year 2007 in Dpmam
5 wordmarks: ADJULYT, ADJUPRAL, ADJUQUAL, ANAFLON, Ambroxocompren, Asteincompren, Asthmochron, Atenocompren, CYCLAN, Cascapride, Cysteincompren, Cysturolon, DOLORESUM, Deprochron, Dormochron …
Year 2007 in Euipotm
13 trademark filings (11 wordmarks, 2 word figurative marks): A WAY OUT OF MIGRAINE, AMOXIL, BENELUPHARM-CURIA, CORVANDIN, IMIGRAN FR, IMIGRAN FTAB, IMIGRAN SPRINTAB, NEXREL, REVINTY, TRIMODA …
27 Mar 2007
Secretary resigned
Year 2006 in Epobase
193 European patent filings: Compounds Having Activity AT 5HT2C Receptor and Uses Thereof …
Year 2006 in Dpmam
2 wordmarks: ACCUHALER, ADJULAT, ADJULYT, ADJUQUA, AIROTAB, ALENIZ, AMPICLOX, ANAVUE, ASTHMOGIT, ATEMUR, ATLAZIR, AUGMENTAN SR, AXOBAN, AXOTIDE, Aeromax …
Year 2006 in Euipotm
13 trademark filings (9 wordmarks, 3 word figurative marks, 1 other mark): ALENYS, ALVANOP, EUMO, HEROLIUS, IMIGRAN SPRINT, NEDAVIN, PROAVAN, RANIMEX, SOSTAN …
26 Sept 2006
Return made up to 15/08/06; full list of members · Secretary's particulars changed
26 Apr 2006 also 14/02/2006
Secretary's particulars changed
Year 2005 in Epobase
182 European patent filings: 1,6-Substituted (3R,6R)-3-(2,3-Dihydro-1H-Inden-2-YL)-2,5-Piperazinedione Derivatives AS Oxytocin Receptor Antagonists for the Treatment of PRE-Term Labour, Dysmenorrhea …
Year 2005 in Euipotm
17 trademark filings (16 wordmarks, 1 word figurative mark): CAPIVIT, EVAMYS, FARINGODOL, FEMINALGIN, FINAMYS, FLIXONASE, FLONASE, LACIREX, LAMITRIN, MAGVIT, MALARONE, PLERBAX, PRONEDA, SERETIDE …
Year 2005 in Dpmam
7 wordmarks: ACTENZA, ACTIVIR, BLISE, BRETHYLAT, CERVOXAN, CICATREX, COLVIR, CORTISPORIN, Comprette, D O L C A N, DARAPRIM, DAVIRAX, DIGIBIND, DOLOGRAN, EURAMIG …
24 Aug 2005
New director appointed
11 Apr 2005
Director resigned
1 Jan 2005
Patent: Verfahren zur Herstellung von Ranitidin
There are no publications matching your search.

Mentions

26 Oct 2026 in Ler
Direct parent
26 Oct 2026 in Ler
Ultimate parent
29 Sept 2026 in Rne
Laboratoires Paucourt SC
29 Sept 2026 in Rne
General partner: Laboratoires ST Germain SC
via Companies House in Cho
Limited Partner: Apollo Therapeutics NO.2 LLP · No longer Limited Partner: Apollo Therapeutics NO.2 LLP · Director (95 companies) · No longer Director (37 companies)
via Companies House in Psc
in Ler
Direct parent (10 companies)
9 Jul 2024 in Ler
Direct parent
27 Mar 2024 in Vr
Reg­is­tra­tion: 19/01/1993 · No longer Director (17) · Director (2) · Change of shareholdings (6 companies) · Capital: 1.10B CZK · Corporate Purpose
6 Apr 2021 in Ler
No longer Ultimate parent
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.